Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A rheumatoid and drug technology, applied in the field of medicine, can solve the problems of long course of treatment, low cure rate, and large side effects, and achieve the effects of inhibiting synthesis and secretion, relieving joint pain, and relieving joint swelling
Pending Publication Date: 2016-06-01
程龙
View PDF6 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] Western medicine is quick to take effect, but it can cure the symptoms but not the root cause, and the drug will relapse immediately after stopping the drug. The side effects are huge, and it is easy to cause life-long diseases and complicati...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] Embodiment 1 A kind of medicine for treating rheumatic rheumatism
[0030] The drug is marine algae glycoprotein;
[0031] Said marine algae glycoprotein, by weight content, comprises sugar 1%, protein 99%,
[0032] The molecular weight is 0.2kDa;
[0033] The marine algae are: cyanobacteria;
[0034] The sugar is a polysaccharide;
[0035] The polysaccharides include: glucose, mannose, rhamnose, galactose;
[0036] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.
Embodiment 2
[0037] Embodiment 2 A kind of medicine for treating rheumatic rheumatoid
[0038] The drug is marine algae glycoprotein;
[0039] Said marine algae glycoprotein, by weight content, comprises sugar 10%, protein 80%,
[0040] The molecular weight is 13kDa;
[0041] The marine algae is: green algae;
[0042] The sugar is a polysaccharide;
[0043] The polysaccharides include: glucose, mannose, rhamnose, galactose;
[0044] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.
Embodiment 3
[0045] Embodiment 3 A kind of medicine for treating rheumatic rheumatoid
[0046] The drug is marine algae glycoprotein;
[0047] Said marine algal glycoprotein, by weight content, comprises sugar 20%, protein 72%,
[0048] The molecular weight is 5kDa;
[0049] The marine algae are: cyanobacteria;
[0050] The sugar is a polysaccharide;
[0051] The polysaccharides include: glucose, mannose, rhamnose, galactose;
[0052] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
Molecular weight
aaaaa
aaaaa
Molecular weight
aaaaa
aaaaa
Molecular weight
aaaaa
aaaaa
Login to view more
Abstract
The invention provides medicine for treating rheumatism and rheumatoid. The medicine is glycoprotein, mixture of polysaccharide and protein, polypeptide or protein. The medicine has the advantages that the joint pain of rat rheumatic arthritis can be relieved effectively, and the joint pain threshold is increased evidently; the joint swelling of the rat rheumatic arthritis can be evidently relieved; rat hypothalamus L-ENK and beta-END contents can be increased, the secretion of proinflammatory factors such as IL-1beta and IL-6 can be lowered, the synthesizing and secretion of serum immunoglobulin IgG can be inhibited, and the release of pain excitation factor SP can be inhibited; the medicine is safe, efficient, free of side effect, and capable of preventing the pantalgia, joint pain and muscle pain caused by the rheumatism and rheumatoid, the joint swelling and pain, joint pain, neck and shoulder pain and waist and back pain not caused by trauma, and the joint pain caused by gout.
Description
technical field [0001] The invention relates to a medicine for treating rheumatism and rheumatoid, belonging to the technical field of medicine. Background technique [0002] Rheumatism and rheumatoid diseases are "stubborn", "difficult" and "very troublesome". They can't be cured for a long time, and they attack repeatedly, which makes patients suffer and doctors have headaches. According to the report of the World Center for Disease Control: Rheumatism and rheumatoid diseases are another intractable disease that seriously threatens human health after cancer. At present, in the United States, Europe and Japan, the number of patients with rheumatism and rheumatoid diseases is as high as nearly 300 million. A survey in some areas of my country shows that 85% of people over the age of 45 suffer from this disease to varying degrees, and the medical expenses paid for it are as high as hundreds of millions of yuan, and there is a further increasing trend. If treatment is delayed...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more